Look Inside A Lab Racing To Develop A Coronavirus Vaccine

The video discusses the efforts of Nova VAX, a Maryland-based company, in developing a coronavirus vaccine. It explains the structure of the virus and how a vaccine could prevent infection. The company aims to start human trials by late spring, despite the usual 18-month timeline. The video also covers the regulatory challenges of vaccine approval and the concept of compassionate use, as seen with Ebola. Finally, it highlights the importance of being prepared for future outbreaks.

What is the primary goal of Nova VAX in developing a coronavirus vaccine?

• To design a vaccine that slows down the virus's evolution

• To produce a vaccine that increases the virus's genetic material

• To develop a vaccine that targets the immune response to block infection

• To create a vaccine that enhances the virus's ability to bind to human cells

How do the spikes on the coronavirus function in the infection process?

• They destroy the human cell's immune response

• They prevent the virus from entering the human body

• They allow the virus to bind to human cells and inject genetic material

• They help the virus to replicate within the human cell

What is the typical timeframe for starting human trials for a vaccine?

• 24 months

• 18 months

• 12 months

• 6 months

What is 'compassionate use' in the context of vaccine approval?

• Using a vaccine in humans before it is fully licensed under dire circumstances

• Using a vaccine only after it is fully approved

• Testing a vaccine on animals before human trials

• Developing a vaccine without any regulatory approval

Why is there urgency in developing a coronavirus vaccine according to Dr. Glenn?

• To increase the virus's mutation rate

• To prepare for a potential second wave of the disease

• To delay the spread of other infectious diseases

• To ensure the virus becomes more potent